Peer Review History
| Original SubmissionAugust 13, 2019 |
|---|
|
PONE-D-19-22885 General practitioners’ perceptions of delayed antibiotic prescription: a phenomenographic study PLOS ONE Dear Mrs Saliba-Gustafsson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Nov 24 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Vijayaprasad Gopichandran Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. Please include additional information regarding the interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, you mention that a pilot guide was tested and altered. On whom was this pilot tested and how many were included? 2. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript reports findings of a qualitative phenomenological study that explored the views of GPs in Malta on delayed antibiotic prescription (DAP). The researchers claim that 'this is the first time GPs' perceptions of DAP have been explored in the Mediterranean region'. Funding seems to indicate that this study is part of a doctoral research program. In general, the reporting in this manuscript seems to have followed the COREQ checklist. I was slightly surprised that the University of Malta HREC has exempted this research from even a minimal risk approval because there are clearly inherent risks of such research with health care professionals - privacy/confidentiality breaches, GPs may feel defensive, GPs may feel they are being scrutinised, GPs may feel obliged to participate, etc. The researchers nevertheless seem to have complied with research ethics protocols. However, whether this is adequate for Plos One, I will leave it with the Editorial Board. Below are my feedback for the researchers' consideration (particularly those wrt methodological concerns): 1. There is inadequate definition and description of DAP in INTRODUCTION. It is a distinct prescribing practice that needs to be defined properly for non-medical readers. 2. Similarly, there is inadequate description of the MASPIC project that the study is supposed to be providing baseline data for. I assume this is the 1st author's doctoral project?? 3. The interviews were conducted in 2014 - 5 years ago?? Why has it taken so long to submit for publication? 4. Description of the 30 GPs contacted and the demographics of the final 20 GPs including Table 1 should be in RESULTS, not METHODS. 5. There is inadequate description of HOW the interview guide was developed. No mention of the questions being translated to Maltese and yet the interviews were conducted in both languages. Presumably then the Maltese interview transcripts would have had to be translated to English as well. Was the translation done by a qualified translator? If not, why not? Was it back-translated to ensure accuracy? 6. Researchers said the three interview questions were open-ended and yet the very first question was a close question. Please explain. 7. The researchers used 'n=' at the end of each of the five themes and these numbers add up to 20, indicating the 20 interviews. I find this totally inappropriate. In fact, throughout DISCUSSION as well as in the last section (outcome space) of RESULTS, the researchers described many areas of overlap of the GPs views across the five categories. So, how can any one interview be so neatly categorised?? I would like the researchers to re-think the way they present their results so that the inherent complexities are not artificially minimised. 8. Discussion was generally well-written although a couple of interesting common features in the five themes were not discussed adequately - eg. GPs seemingly distrust of pharmacists, GPs' views that patients are generally non-compliant. 9. I thought the use of Hofstede's national culture model to help explain the differences in prescribing habits in different countries is appropriate. However, there is inadequate explanation of the dimensions in the model particularly 'uncertainty avoidance' and 'power distance'. 10. Researchers recommend further research to explore patients' views on DAP. Given pharmacists' important role in DAP and yet GPs in this study seemed to have mixed feelings about pharmacists' effectiveness, it will also be necessary to explore pharmacists' views or include pharmacists in future research to ensure the integrity of the implementation of DAP. I think some discussion of this aspect (pharmacists' role) of DAP is also necessary in DISCUSSION. Reviewer #2: Summary In their manuscript, “General practitioners perceptions of delayed antibiotic prescription: a phenomenographic study,” Saliba-Gustafsson and colleagues describe a qualitative study of the attitudes of Maltese General Practitioners (GPs) towards delayed antibiotic prescriptions (DAP). The investigators developed an English-language interview guide that covered many topics having to do with antibiotic resistance, antibiotic use, and antibiotic prescribing, including DAP; conducted 20 interviews with GPs; recorded and transcribed the conversations; and had 2 investigators concurrently code the transcripts using a phenomenographic approach. The investigators divided the 20 respondents into 5 groups based on attitudes towards DAP: 1) Service Providers, 2) Uncertainty Avoiders, 3) Comforters, 4) Conscientious Practitioners, and 5) Power Holders. Major Comments The topic is interesting and important. Delayed antibiotic prescribing is used widely, studied often, mentioned in many antibiotic prescribing guidelines, and is controversial. The quotes provided by the authors are illustrative. To reveal my own bias, I think delayed antibiotic prescribing is a bad idea for a host of reasons. Guidelines are clear about when to use antibiotics for most respiratory tract infections. DAP ignore the natural history of respiratory infections (pharyngitis lasts for 5-7 days, colds 10-14 days, acute bronchitis 3 weeks); does not make microbiological sense; sends a confusing, mixed-message to patients; and does not improve patient outcomes. In using DAP, physicians are abdicating their professional responsibility to patients. Thus, I would categorize myself as a “Power Holder.” Despite being a “Power Holder,” I recognize the potential of “perfection being the worst enemy of the good,” and am open to the possibility that DAP has the potential to reduce overall antibiotic use in the right circumstances. I have a few General Comments about the conduct of the study and reporting of the manuscript. First, the interview was much broader than simply asking the GPs about delayed antibiotic prescribing. As such, it is unclear how the coding, analysis, and development of the “graphical space” in the present manuscript relates to other topics covered in the interview guide. How did the investigators decide to focus a manuscript on delayed antibiotic prescribing? Are there other manuscripts that the investigators have or anticipate will emerge from these data? Second, it is overly simplistic that GPs be categorized into mutually exclusive groups. Individual GPs probably have multiple attitudes and rationales for DAP. Individual GPs could have expressed multiple reasons for DAP. For me personally, as a physician who would probably be categorized here as a “Power Holder,” I like to think that I also practice conscientiously, comfort my patients, and provide good service. Occasionally, I might even strive to avoid uncertainty. Similarly, the GPs in this study did not simply announce themselves in one of these 5 categories. There must have been varying degrees of overlap. Third, in the Abstract and generally, the authors are never explicit about what clinical situations the GPs are considering when discussing DAP. The three general questions about DAP on page 7, likewise, do not specify a particular clinical situation. Could the GPs have had very different things in mind when discussing DAP? Were they considering only treatment of respiratory infections? Urinary symptoms? GI problems? Other situations? Minor Comments Page 3, Line 48: The authors state “This study shows numerous behavioral drivers impact how delayed antibiotic prescription is perceived,” but the term “behavioral drivers” is not defined and is unclear. “Behavioral drivers” sounds like much more specific factors (e.g., environmental cues) that lead to simpler behaviors (e.g., poor diet), rather than the complex socio-cognitive-emotional factors that are leading to the complex behavior of DAP. Page 4, Line 75: The authors make an excellent argument against DAP. They should make sure that DAP be implemented carefully and conscientiously in the right circumstances if it is principally being used to decrease inappropriate antibiotic use. Page 5, Line 86: For context, the authors should provide actual metrics of antibiotic use in Malta and comparison countries (high and low utilizing). Other contextual information that would be helpful to the reader would be monthly average Maltese income, the cost of a GP visit, and the out-of-pocket cost of antibiotics. Page 8, Line 162: Here and elsewhere in the manuscript, the authors need to clarify what they mean by “bracketing their own preconceptions.” It sounds like they are literally using brackets to indicate their own preconceived notions when coding and analyzing the qualitative data. Is that what they mean or is this a more general, figurative term for keeping their own preconceived notions in mind? Page 10, Line 202: Here and in other places in the manuscript, the authors imply that having the patient call the GP is not an option. In the US, a major reason given for delayed antibiotic prescribing (and antibiotic overprescribing) is efficiency: clinicians do not have time to field phone calls from patients following-up. I was surprised to not see this come up as a reason or a GP archetype (“Efficiency Seekers” maybe). Page 15, Line 328: The term “Power Holder” has a negative connotation. The 5 GPs who are in this category are doing what they feel, in their best professional opinion, is in their patients’ best interest. A less negative term, like “Professionally Focused” or “Responsibility,” would be better. Page 18, Line 390: It is not right that “other modes of delivery…were not mentioned by the informants.” There is discussion about returning and calling the clinic. Page 20, Line 432: Suddenly only referring to the GP categories by letter designations makes the text very hard to follow. The authors should continue using the descriptive categories. Page 20, Line 433: The authors state that Categories B and C “consistently [applied]” DAP, but it seems that only Category A, “Service Providers,” were consistent in giving out DAPs. The authors need to clarify. Page 20, Line 449 (as well as Page 4, Line 69): I am skeptical that “low-cost, rapid diagnostic testing” is going to solve antibiotic overprescribing. There is ample evidence of testing being unused or the results being “ignored,” as the authors themselves point out. Most inappropriate antibiotic prescribing is not a result of a lack of diagnostic knowledge – you don’t need more information when someone clinically has a cold – but a result of emotional, social, and cultural factors. Page 21, Line 454: In describing antibiotic prescribing in the face of a negative rapid antigen test, presumably this was for pharyngitis. Page 21, Line 461: The authors write “These GPs exhibited a more paternalistic consultation style…” But there were no actual observations of practice in this study. This needs to be reworded such that – if this is true – the GPs “described” a more paternalistic style. (As noted above, I am concerned that the authors are making judgements about the “Power Holders,” that they are not about the other groups.) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
General practitioners’ perceptions of delayed antibiotic prescription for respiratory tract infections: a phenomenographic study PONE-D-19-22885R1 Dear Dr. Saliba-Gustafsson, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Vijayaprasad Gopichandran Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-22885R1 General practitioners’ perceptions of delayed antibiotic prescription for respiratory tract infections: a phenomenographic study Dear Dr. Saliba-Gustafsson: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vijayaprasad Gopichandran Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .